Ala-Gln
CAS No. 39537-23-0
Ala-Gln ( l-alanyl-l-glutamine )
产品货号. M20340 CAS No. 39537-23-0
Ala-Gln是由丙氨酸和Gln组成的二肽,是生物制药生产中L-谷氨酰胺的替代补充剂,比谷氨酰胺(Gln)具有更好的溶解度和稳定性。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 25MG | ¥219 | 有现货 |
|
| 100MG | ¥411 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Ala-Gln
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Ala-Gln是由丙氨酸和Gln组成的二肽,是生物制药生产中L-谷氨酰胺的替代补充剂,比谷氨酰胺(Gln)具有更好的溶解度和稳定性。
-
产品描述Ala-Gln a dipeptide composed of alanine and Gln is an alternative supplement to L-glutamine in the production of biopharmaceuticals with better solubility and stability than glutamine (Gln).(In Vitro):L-Alanyl-L-glutamine (2 mM; 24?hours) partially or fully attenuates chronic insulin secretion, and IR-β and COX IV levels which are decreased when β-cells were exposed to macrophages following stimulation in vitro (IMMs).L-Alanyl-L-glutamine -dependent β-cell protection mediated by coordinated effects on the glutamine-GSH axis, and the HSP pathway, maintenance of mitochondrial metabolism and stimulus-secretion coupling essential for insulin release.
-
体外实验L-Alanyl-L-glutamine (2 mM; 24?hours) partially or fully attenuates chronic insulin secretion, and IR-β and COX IV levels which are decreased when β-cells were exposed to macrophages following stimulation in vitro (IMMs). L-Alanyl-L-glutamine -dependent β-cell protection mediated by coordinated effects on the glutamine-GSH axis, and the HSP pathway, maintenance of mitochondrial metabolism and stimulus-secretion coupling essential for insulin release.
-
体内实验——
-
同义词l-alanyl-l-glutamine
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域Inflammation/Immunology
-
适应症Peritonitis
化学信息
-
CAS Number39537-23-0
-
分子量217.22
-
分子式C8H15N3O4
-
纯度>98% (HPLC)
-
溶解度H2O:43 mg/mL (197.96 mM)
-
SMILESC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O
-
化学全称L-alanyl-L-glutamine
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
TL4-12
TL4-12 是一种选择性 MAP4K2/GCK 抑制剂,下调 IKZF1 和 BCL-6,并抑制 MM 细胞增殖 (IC50=37 nM) 并诱导细胞凋亡。TL4-12 可用于克服多发性骨髓瘤 (MM) 中免疫调节剂的耐药性。
-
Biotin-Insulin Recep...
Biotin-Insulin Receptor (1142-1153)
-
CJJ300
CJJ300 是一个转化生长因子-β (TGF-β) 抑制剂, IC50 值为 5.3 μM。CJJ300 通过阻断 TGF-β-TβR-I-TβR-II signaling complex 的形成来抑制 TGF-β signaling。
021-51111890
购物车()
sales@molnova.cn

